Nasal vaccines

被引:248
作者
Davis, SS [1 ]
机构
[1] Univ Nottingham, Inst Pharmaceut Sci, Nottingham NG7 2RD, England
关键词
nasal vaccines; nose-associated lymphoid tissue; Waldeyer's ring; tonsils; common mucosal immune system;
D O I
10.1016/S0169-409X(01)00162-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The nasal route for vaccination offers some important opportunities, especially for the prophylaxis of respiratory diseases. Vaccination via the respiratory tract is reviewed and the deposition and clearance of antigens in the deep lung and nose are described and contrasted. Lymphoid structures in the respiratory tract differ according to species; the rat and mouse have a well developed nose-associated lymphoid tissue, while in man, the structure known as Waldeyer's ring (that includes the tonsils), is important as an induction site. The immune response following intranasal administration can provide protection at the administration site and at various effector sites as part of the common mucosal immune system. A number of formulation considerations are important when designing novel systems for nasal administration as are physiological factors such as mucociliary clearance. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:21 / 42
页数:22
相关论文
共 166 条
[1]   Intranasal booster vaccination against diphtheria and tetanus in man [J].
Aggerbeck, H ;
Gizurarson, S ;
Wantzin, J ;
Heron, I .
VACCINE, 1997, 15 (03) :307-316
[2]   ΔguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin [J].
Anderson, RJ ;
Pasetti, MF ;
Sztein, MB ;
Levine, MM ;
Noriega, FR .
VACCINE, 2000, 18 (21) :2193-2202
[3]  
[Anonymous], 1999, MUCOSAL IMMUNOL
[4]   ACTIVATION OF SYSTEMIC AND MUCOSAL IMMUNE-RESPONSE FOLLOWING NASAL ADMINISTRATION OF LIPOSOMES [J].
ARAMAKI, Y ;
FUJII, Y ;
YACHI, K ;
KIKUCHI, H ;
TSUCHIYA, S .
VACCINE, 1994, 12 (13) :1241-1245
[5]   Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity [J].
Arulanandam, BP ;
O'Toole, M ;
Metzger, DW .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04) :940-949
[6]   IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration [J].
Asanuma, H ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
VACCINE, 1998, 16 (13) :1257-1262
[7]   Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice [J].
Astori, M ;
von Garnier, C ;
Kettner, A ;
Dufour, N ;
Corradin, G ;
Spertini, F .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3497-3505
[8]   Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12 [J].
Baca-Estrada, ME ;
Foldvari, M ;
Snider, M .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (05) :455-462
[9]   Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses [J].
Baca-Estrada, ME ;
Foldvari, M ;
Snider, M ;
Harding, K ;
Kournikakis, B ;
Babiuk, LA ;
Griebel, P .
VACCINE, 2000, 18 (21) :2203-2211
[10]   Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration [J].
Baldridge, JR ;
Yorgensen, Y ;
Ward, JR ;
Ulrich, JT .
VACCINE, 2000, 18 (22) :2416-2425